PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 137 filers reported holding PUMA BIOTECHNOLOGY INC in Q1 2014. The put-call ratio across all filers is 1.88 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2016 | $5,175,000 | -68.5% | 176,202 | -17.9% | 0.01% | -69.0% |
| Q4 2015 | $16,434,000 | -7.4% | 214,746 | -8.8% | 0.03% | -12.1% |
| Q3 2015 | $17,749,000 | +14.8% | 235,533 | +77.9% | 0.03% | +32.0% |
| Q2 2015 | $15,459,000 | +993.3% | 132,412 | +2109.4% | 0.02% | +733.3% |
| Q1 2015 | $1,414,000 | +33.9% | 5,993 | +7.6% | 0.00% | +50.0% |
| Q4 2014 | $1,056,000 | +13.3% | 5,570 | +42.6% | 0.00% | 0.0% |
| Q3 2014 | $932,000 | +47.5% | 3,906 | +34.7% | 0.00% | +100.0% |
| Q2 2014 | $632,000 | +857.6% | 2,900 | +227.7% | 0.00% | – |
| Q1 2014 | $66,000 | -74.4% | 885 | -81.6% | 0.00% | – |
| Q3 2013 | $258,000 | +24.0% | 4,816 | +2.5% | 0.00% | – |
| Q2 2013 | $208,000 | – | 4,698 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 200,000 | $20,706,000 | 6.01% |
| Redmile Group, LLC | 230,673 | $23,882,000 | 2.95% |
| WEATHERBIE CAPITAL, LLC | 241,419 | $24,994,000 | 2.31% |
| Tekla Capital Management LLC | 185,820 | $19,238,000 | 2.02% |
| Ghost Tree Capital, LLC | 25,000 | $2,588,000 | 1.59% |
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 5,686,668 | $588,741,000 | 1.56% |
| Iguana Healthcare Management, LLC | 25,000 | $2,588,000 | 1.48% |
| Eventide Asset Management | 42,100 | $4,359,000 | 1.34% |
| Bain Capital Public Equity Management, LLC | 401,330 | $41,550,000 | 1.17% |
| Rock Springs Capital Management LP | 31,500 | $3,261,000 | 1.16% |